Free Trial

Glaukos (GKOS) News Today

Glaukos logo
$148.36 -2.52 (-1.67%)
(As of 05:26 PM ET)
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
Glaukos: Still Bullish, But Embedded Expectations Are Now High
Glaukos (NYSE:GKOS) Hits New 12-Month High on Analyst Upgrade
Glaukos (GKOS) Receives a Buy from Stifel Nicolaus
Glaukos Co. stock logo
Glaukos (NYSE:GKOS) Hits New 1-Year High Following Analyst Upgrade
Glaukos (NYSE:GKOS) Reaches New 12-Month High on Analyst Upgrade
Short Interest in Glaukos Co. (NYSE:GKOS) Declines By 5.3%
Glaukos price target raised to $185 from $152 at Truist
Glaukos Co. stock logo
Truist Financial Issues Positive Forecast for Glaukos (NYSE:GKOS) Stock Price
Truist Financial boosted their price objective on Glaukos from $152.00 to $185.00 and gave the stock a "buy" rating in a research note on Wednesday.
Glaukos Co. stock logo
Tidal Investments LLC Purchases 6,767 Shares of Glaukos Co. (NYSE:GKOS)
Tidal Investments LLC boosted its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 83.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,908 shares of the medical instruments
Glaukos Co. stock logo
Geode Capital Management LLC Acquires 66,134 Shares of Glaukos Co. (NYSE:GKOS)
Geode Capital Management LLC grew its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 6.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,172,016 shares of the medical instruments supplier's stock a
Glaukos Co. stock logo
Glaukos Co. (NYSE:GKOS) Shares Purchased by Barclays PLC
Barclays PLC grew its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 394.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 89,699 shares of the medical instruments supplier'
Glaukos Co. stock logo
Glaukos Co. (NYSE:GKOS) Short Interest Down 5.3% in November
Glaukos Co. (NYSE:GKOS - Get Free Report) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 2,660,000 shares, a decrease of 5.3% from the November 15th total of 2,810,000 shares. Based on an average daily volume of 526,000 shares, the short-interest ratio is presently 5.1 days.
Glaukos Co. stock logo
Teachers Retirement System of The State of Kentucky Grows Position in Glaukos Co. (NYSE:GKOS)
Teachers Retirement System of The State of Kentucky increased its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 84.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 28,470 shares of the medical instruments
Glaukos (NYSE:GKOS) Upgraded at Citigroup
Glaukos Co. stock logo
Gilbert H. Kliman Sells 2,000 Shares of Glaukos Co. (NYSE:GKOS) Stock
Glaukos Co. (NYSE:GKOS - Get Free Report) Director Gilbert H. Kliman sold 2,000 shares of the business's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $144.01, for a total value of $288,020.00. Following the completion of the sale, the director now owns 32,336 shares of the company's stock, valued at $4,656,707.36. This trade represents a 5.82 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Glaukos Co. stock logo
Y Intercept Hong Kong Ltd Takes $1.01 Million Position in Glaukos Co. (NYSE:GKOS)
Y Intercept Hong Kong Ltd bought a new position in Glaukos Co. (NYSE:GKOS - Free Report) in the third quarter, according to its most recent filing with the SEC. The firm bought 7,724 shares of the medical instruments supplier's stock, valued at approximately $1,006,000. Several other large investor
Glaukos (NYSE:GKOS) Stock Price Up 5.4% Following Analyst Upgrade
Glaukos (GKOS) Receives a Buy from J.P. Morgan
Citigroup Upgrades Glaukos (GKOS)
Glaukos Co. stock logo
State Street Corp Raises Stock Holdings in Glaukos Co. (NYSE:GKOS)
State Street Corp raised its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 5.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,954,449 shares of the medical instruments supplier's stock after purchasing an addi
Wells Fargo Sticks to Its Buy Rating for Glaukos (GKOS)
Glaukos Co. stock logo
Glaukos (NYSE:GKOS) Rating Increased to Buy at Citigroup
Citigroup upgraded shares of Glaukos from a "neutral" rating to a "buy" rating and raised their price objective for the company from $132.00 to $162.00 in a research note on Wednesday.
Glaukos Co. stock logo
Glaukos Co. (NYSE:GKOS) Shares Bought by Wellington Management Group LLP
Wellington Management Group LLP lifted its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 294.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 2,183,766 shares of the medical instruments supplier's stock after acquiring an additional 1,63
Glaukos Co. stock logo
BNP Paribas Financial Markets Grows Stock Holdings in Glaukos Co. (NYSE:GKOS)
BNP Paribas Financial Markets lifted its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 186.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,726 shares of the medical instruments supp
Glaukos Co. stock logo
Glaukos (NYSE:GKOS) Earns Buy Rating from Analysts at UBS Group
UBS Group began coverage on shares of Glaukos in a research note on Friday. They issued a "buy" rating and a $182.00 price target on the stock.
Glaukos Co. stock logo
Point72 Asset Management L.P. Sells 186,605 Shares of Glaukos Co. (NYSE:GKOS)
Point72 Asset Management L.P. reduced its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 32.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 383,396 shares of the medical instruments supplier's stock after sellin
Glaukos Co. stock logo
Janus Henderson Group PLC Trims Position in Glaukos Co. (NYSE:GKOS)
Janus Henderson Group PLC lowered its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 9.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,325,784 shares of the medical instruments supplier'
Morgan Stanley Downgrades Glaukos (GKOS)
Glaukos downgraded to Underweight from Equal Weight at Morgan Stanley
Glaukos price target raised to $153 from $145 at Stifel
Glaukos Co. stock logo
Glaukos (NYSE:GKOS) Rating Lowered to Underweight at Morgan Stanley
Morgan Stanley downgraded shares of Glaukos from an "equal weight" rating to an "underweight" rating and set a $120.00 price target for the company. in a research report on Monday.
Glaukos Co. stock logo
Bellevue Group AG Grows Stock Holdings in Glaukos Co. (NYSE:GKOS)
Bellevue Group AG lifted its position in Glaukos Co. (NYSE:GKOS - Free Report) by 12.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 62,983 shares of the medical instruments supplier's stock after buying a
Glaukos Co. stock logo
Glaukos Co. (NYSE:GKOS) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Glaukos Co. (NYSE:GKOS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have given a buy rating to
Glaukos Co. stock logo
Glaukos Co. (NYSE:GKOS) Shares Sold by Fred Alger Management LLC
Fred Alger Management LLC reduced its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 15.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,076,974 shares of the med
Glaukos Co. stock logo
Braidwell LP Sells 184,960 Shares of Glaukos Co. (NYSE:GKOS)
Braidwell LP decreased its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 37.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 311,616 shares of the medical instruments supplier's stock a
Glaukos Co. stock logo
Public Sector Pension Investment Board Increases Stock Position in Glaukos Co. (NYSE:GKOS)
Public Sector Pension Investment Board raised its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 5.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 116,605 shares of the medical instruments supplier
Glaukos Co. stock logo
Zacks Research Issues Positive Outlook for Glaukos Earnings
Glaukos Co. (NYSE:GKOS - Free Report) - Analysts at Zacks Research lifted their FY2024 earnings estimates for shares of Glaukos in a report released on Monday, November 25th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings per share o
Glaukos Co. stock logo
Fmr LLC Cuts Stake in Glaukos Co. (NYSE:GKOS)
Fmr LLC reduced its position in Glaukos Co. (NYSE:GKOS - Free Report) by 39.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,584,488 shares of the medical instruments supplier's stock after sel
Glaukos Co. stock logo
Algert Global LLC Purchases 8,206 Shares of Glaukos Co. (NYSE:GKOS)
Algert Global LLC raised its position in Glaukos Co. (NYSE:GKOS - Free Report) by 162.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,260 shares of the medical instruments sup
Glaukos Co. stock logo
Charles Schwab Investment Management Inc. Has $83.61 Million Position in Glaukos Co. (NYSE:GKOS)
Charles Schwab Investment Management Inc. raised its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 47.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 641,761 shares of the medical instruments supplier's stock
Glaukos price target raised to $149 from $140 at BTIG
Glaukos Co. stock logo
Loomis Sayles & Co. L P Grows Position in Glaukos Co. (NYSE:GKOS)
Loomis Sayles & Co. L P grew its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 21.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 673,751 shares of the medical instruments
Glaukos Co. stock logo
Eagle Asset Management Inc. Has $11.12 Million Stake in Glaukos Co. (NYSE:GKOS)
Eagle Asset Management Inc. trimmed its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 12.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,455 shares of the medical instruments s
Glaukos Co. stock logo
Intech Investment Management LLC Purchases 9,088 Shares of Glaukos Co. (NYSE:GKOS)
Intech Investment Management LLC lifted its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 79.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,462 shares of the medical instruments supp
Glaukos Co. stock logo
6,080 Shares in Glaukos Co. (NYSE:GKOS) Bought by Jennison Associates LLC
Jennison Associates LLC acquired a new stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 6,080 shares of the medical instruments supplier's stock, valued at approximately $792,000. A number
Glaukos Co. stock logo
Connor Clark & Lunn Investment Management Ltd. Has $6.11 Million Position in Glaukos Co. (NYSE:GKOS)
Connor Clark & Lunn Investment Management Ltd. lessened its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 47.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 46,913 shares of the medical instruments supplier's stock after selling 42,798 shar
Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.

70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 

GKOS Media Mentions By Week

GKOS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GKOS
News Sentiment

0.95

0.60

Average
Medical
News Sentiment

GKOS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GKOS Articles
This Week

15

6

GKOS Articles
Average Week

Get Glaukos News Delivered to You Automatically

Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:GKOS) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners